The Danish High-Risk and Resilience Study-VIA 15 - A Study Protocol for the Third Clinical Assessment of a Cohort of 522 Children Born to Parents Diagnosed With Schizophrenia or Bipolar Disorder and Population-Based Controls.
adolescent mental health
bipolar disorder
developmental trajectories
familial high risk
schizophrenia
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
11
2021
accepted:
28
01
2022
entrez:
21
4
2022
pubmed:
22
4
2022
medline:
22
4
2022
Statut:
epublish
Résumé
Children born to parents with severe mental illness have gained more attention during the last decades because of increasing evidence documenting that these children constitute a population with an increased risk of developing mental illness and other negative life outcomes. Because of high-quality research with cohorts of offspring with familial risk and increased knowledge about gene-environment interactions, early interventions and preventive strategies are now being developed all over the world. Adolescence is a period characterized by massive changes, both in terms of physical, neurologic, psychological, social, and behavioral aspects. It is also the period of life with the highest risk of experiencing onset of a mental disorder. Therefore, investigating the impact of various risk and resilience factors in adolescence is important. The Danish High-Risk and Resilience Study started data collection in 2012, where 522 7-year-old children were enrolled in the first wave of the study, the VIA 7 study. The cohort was identified through Danish registers based on diagnoses of the parents. A total of 202 children had a parent diagnosed with schizophrenia, 120 children had a parent diagnosed with bipolar disorder, and 200 children had parents without these diagnoses. At age 11 years, all children were assessed for the second time in the VIA 11 study, with a follow-up retention rate of 89%. A comprehensive assessment battery covering domains of psychopathology, neurocognition, social cognition and behavior, motor development and physical health, genetic analyses, attachment, stress, parental functioning, and home environment was carried out at each wave. Magnetic resonance imaging scans of the brain and electroencephalograms were included from age 11 years. This study protocol describes the third wave of assessment, the VIA 15 study, participants being 15 years of age and the full, 3-day-long assessment battery this time including also risk behavior, magnetoencephalography, sleep, and a white noise paradigm. Data collection started on May 1, 2021. We will discuss the importance of longitudinal studies and cross-sectional data collection and how studies like this may inform us about unmet needs and windows of opportunity for future preventive interventions, early illness identification, and treatment in the future.
Sections du résumé
Background
UNASSIGNED
Children born to parents with severe mental illness have gained more attention during the last decades because of increasing evidence documenting that these children constitute a population with an increased risk of developing mental illness and other negative life outcomes. Because of high-quality research with cohorts of offspring with familial risk and increased knowledge about gene-environment interactions, early interventions and preventive strategies are now being developed all over the world. Adolescence is a period characterized by massive changes, both in terms of physical, neurologic, psychological, social, and behavioral aspects. It is also the period of life with the highest risk of experiencing onset of a mental disorder. Therefore, investigating the impact of various risk and resilience factors in adolescence is important.
Methods
UNASSIGNED
The Danish High-Risk and Resilience Study started data collection in 2012, where 522 7-year-old children were enrolled in the first wave of the study, the VIA 7 study. The cohort was identified through Danish registers based on diagnoses of the parents. A total of 202 children had a parent diagnosed with schizophrenia, 120 children had a parent diagnosed with bipolar disorder, and 200 children had parents without these diagnoses. At age 11 years, all children were assessed for the second time in the VIA 11 study, with a follow-up retention rate of 89%. A comprehensive assessment battery covering domains of psychopathology, neurocognition, social cognition and behavior, motor development and physical health, genetic analyses, attachment, stress, parental functioning, and home environment was carried out at each wave. Magnetic resonance imaging scans of the brain and electroencephalograms were included from age 11 years. This study protocol describes the third wave of assessment, the VIA 15 study, participants being 15 years of age and the full, 3-day-long assessment battery this time including also risk behavior, magnetoencephalography, sleep, and a white noise paradigm. Data collection started on May 1, 2021.
Discussion
UNASSIGNED
We will discuss the importance of longitudinal studies and cross-sectional data collection and how studies like this may inform us about unmet needs and windows of opportunity for future preventive interventions, early illness identification, and treatment in the future.
Identifiants
pubmed: 35444571
doi: 10.3389/fpsyt.2022.809807
pmc: PMC9013818
doi:
Types de publication
Journal Article
Langues
eng
Pagination
809807Informations de copyright
Copyright © 2022 Thorup, Hemager, Bliksted, Greve, Ohland, Wilms, Rohd, Birk, Bundgaard, Laursen, Jefsen, Steffensen, Andreassen, Veddum, Knudsen, Enevoldsen, Nymand, Brandt, Søndergaard, Carmichael, Gregersen, Krantz, Burton, Dietz, Nudel, Johnsen, Larsen, Meder, Hulme, Baaré, Madsen, Lund, Østergaard, Juul, Kjær, Hjorthøj, Siebner, Mors and Nordentoft.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Psychol Med. 2017 Jan;47(2):377-388
pubmed: 27776572
BMC Neurosci. 2020 Jul 7;21(1):30
pubmed: 32635940
Psychol Med. 2021 Oct;51(14):2321-2336
pubmed: 34435556
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Lancet. 2018 Oct 27;392(10157):1553-1598
pubmed: 30314863
Schizophr Res. 2015 Oct;168(1-2):197-203
pubmed: 26363969
Front Psychiatry. 2018 Dec 12;9:661
pubmed: 30631284
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
J Child Psychol Psychiatry. 2016 Mar;57(3):353-68
pubmed: 26889896
Psychiatry Res. 1996 Dec 20;65(3):189-98
pubmed: 9029668
Nature. 2010 Nov 11;468(7321):187-93
pubmed: 21068826
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
World Psychiatry. 2018 Jun;17(2):210-219
pubmed: 29856544
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Aug;3(8):704-712
pubmed: 29909148
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Can J Public Health. 2013 Feb 11;104(2):e131-5
pubmed: 23618205
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Biol Psychiatry. 2021 Jan 15;89(2):109-118
pubmed: 33190844
Lancet Psychiatry. 2018 Jul;5(7):591-604
pubmed: 29773478
Schizophr Bull. 2014 Jan;40(1):28-38
pubmed: 23960245
Cereb Cortex. 2016 Jan;26(1):257-267
pubmed: 25246511
Dan Med Bull. 1999 Jun;46(3):263-8
pubmed: 10421985
Sleep Med Rev. 2017 Apr;32:69-84
pubmed: 27061476
J Psychiatr Ment Health Nurs. 2018 Mar;25(2):131-141
pubmed: 28776896
Arch Dis Child. 1969 Jun;44(235):291-303
pubmed: 5785179
Eur Psychiatry. 2017 Jul;44:17-23
pubmed: 28531561
Biol Psychiatry. 2021 Jan 15;89(2):93-95
pubmed: 33334433
Sci Rep. 2014 Sep 01;4:6240
pubmed: 25174814
Q J Exp Psychol (Hove). 2008 Jan;61(1):40-9
pubmed: 18038337
Personal Disord. 2012 Jan;3(1):39-54
pubmed: 22448860
J Affect Disord. 2013 Sep 5;150(2):363-9
pubmed: 23707033
Sleep Med Rev. 2019 Aug;46:151-160
pubmed: 31154154
Clin Psychol (New York). 2010 Dec;17(4):272-280
pubmed: 21243110
Schizophr Bull. 2017 Oct 21;43(6):1158-1163
pubmed: 29036635
Biol Psychiatry. 2017 Nov 15;82(10):746-755
pubmed: 28734460
Br J Clin Psychol. 2003 Mar;42(Pt 1):53-67
pubmed: 12675979
Front Psychiatry. 2020 Jul 10;11:632
pubmed: 32754058
Neurosci Biobehav Rev. 2016 Nov;70:106-120
pubmed: 27545755
BMC Psychiatry. 2014 Dec 02;14:344
pubmed: 25439055
JAMA Psychiatry. 2016 Nov 01;73(11):1145-1153
pubmed: 27732692
Eur Child Adolesc Psychiatry. 2020 Jun;29(6):849-860
pubmed: 31494772
Neuron. 2021 Sep 15;109(18):2820-2846
pubmed: 34270921
Ugeskr Laeger. 2003 Jan 27;165(5):462-5
pubmed: 12599845
Mol Psychiatry. 2020 Aug;25(8):1631-1639
pubmed: 31959848
PLoS One. 2020 May 26;15(5):e0233696
pubmed: 32453799
Assessment. 2014 Dec;21(6):694-705
pubmed: 24852496
Nat Rev Neurosci. 2008 Dec;9(12):947-57
pubmed: 19002191
J Res Adolesc. 2011 Mar 1;21(1):21-33
pubmed: 21475613
Early Interv Psychiatry. 2021 Jun;15(3):676-685
pubmed: 32575146
J Neurosci Methods. 1994 Apr;52(1):39-45
pubmed: 8090015
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
Am J Psychiatry. 2019 Mar 1;176(3):179-185
pubmed: 30818985
Autism Res. 2020 Mar;13(3):369-381
pubmed: 31577390
Genome Biol. 2004;5(10):R80
pubmed: 15461798
JAMA Psychiatry. 2018 Aug 1;75(8):844-852
pubmed: 29926086
Schizophr Bull. 2009 Nov;35(6):1045-56
pubmed: 19783603
J Child Psychol Psychiatry. 2021 Dec 16;:
pubmed: 34918345
Arch Dis Child. 1970 Feb;45(239):13-23
pubmed: 5440182
Neurosci Biobehav Rev. 2018 Sep;92:417-436
pubmed: 29972766
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
Cogn Neuropsychiatry. 2013;18(1-2):44-82
pubmed: 22998599
Neuroimage. 2013 Oct 15;80:169-89
pubmed: 23684877
Lancet Psychiatry. 2017 May;4(5):400-408
pubmed: 28344044
Harv Rev Psychiatry. 2016 Mar-Apr;24(2):104-17
pubmed: 26954595
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Neurotoxicol Teratol. 2019 Nov - Dec;76:106834
pubmed: 31505230
Child Abuse Negl. 2019 Aug;94:104026
pubmed: 31154112
Adv Child Dev Behav. 2015;48:53-92
pubmed: 25735941
J Neurosci. 2011 Jul 27;31(30):10937-47
pubmed: 21795544
Wiley Interdiscip Rev Cogn Sci. 2017 Jan;8(1-2):
pubmed: 27906514
Nature. 2020 Jan;577(7792):671-675
pubmed: 31942076
Arthritis. 2018 Mar 1;2018:6596278
pubmed: 29686901
J Psychosom Res. 2020 Nov;138:110245
pubmed: 32950761
Cereb Cortex. 2017 Feb 1;27(2):1472-1481
pubmed: 28365755
Schizophr Res. 2021 Feb;228:510-518
pubmed: 33308959
Assessment. 2015 Oct;22(5):527-39
pubmed: 25604630
Arch Gen Psychiatry. 2009 Mar;66(3):287-96
pubmed: 19255378
Genome Biol. 2014 Dec 03;15(12):503
pubmed: 25599564
Neuropsychopharmacology. 2015 Jan;40(1):141-53
pubmed: 24917200
BMC Psychiatry. 2015 Oct 02;15:233
pubmed: 26432691
J Psychosom Res. 2015 Jun;78(6):536-45
pubmed: 25818346
Psychol Med. 2016 Oct;46(13):2731-40
pubmed: 27444712
Schizophr Res. 2020 Jul;221:29-36
pubmed: 31753592
Biol Psychiatry. 2021 Jan 15;89(2):99-108
pubmed: 33334434
Schizophr Res. 2003 Apr 1;60(2-3):239-58
pubmed: 12591587
Acta Psychiatr Scand. 2000 Apr;101(4):323-9
pubmed: 10782554
Biol Psychiatry. 2021 Jan 15;89(2):184-193
pubmed: 32896384
Child Neuropsychol. 2000 Sep;6(3):235-8
pubmed: 11419452
J Pers Assess. 1990 Winter;55(3-4):610-7
pubmed: 2280326
MMWR Recomm Rep. 2013 Mar 1;62(RR-1):1-20
pubmed: 23446553
J Neurosci. 2008 Apr 2;28(14):3586-94
pubmed: 18385317
Acta Psychiatr Scand. 2019 Aug;140(2):126-134
pubmed: 31155701
Compr Psychiatry. 2018 Nov;87:143-152
pubmed: 30415196
Dan Med Bull. 2006 Nov;53(4):441-9
pubmed: 17150149
Neuroimage. 2000 Sep;12(3):314-25
pubmed: 10944414
Curr Opin Neurobiol. 2016 Oct;40:81-85
pubmed: 27420376
Psychiatr Genet. 2019 Oct;29(5):160-169
pubmed: 31464997
Eur Child Adolesc Psychiatry. 2021 Dec;30(12):1871-1884
pubmed: 33025076
Schizophr Bull. 2019 Oct 24;45(6):1218-1230
pubmed: 30852621